Cargando…
Response to Nivolumab followed by complete cytoreductive surgery with HIPEC resulted in long-term survival in a patient with sarcomatoid-predominant biphasic peritoneal mesothelioma. A case report
INTRODUCTION AND IMPORTANCE: Sarcomatoid-predominant biphasic peritoneal metastases is a rapidly progressing and deeply invasive variant of this disease with survival measured in months. Although cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a standard of care...
Autor principal: | Sugarbaker, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310908/ https://www.ncbi.nlm.nih.gov/pubmed/37267791 http://dx.doi.org/10.1016/j.ijscr.2023.108359 |
Ejemplares similares
-
Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case
por: Sugarbaker, Paul H.
Publicado: (2021) -
Long-term survival is possible using cytoreductive surgery plus HIPEC for sarcomatosis—Case report of 2 patients
por: Sugarbaker, Paul H.
Publicado: (2019) -
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014) -
Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015) -
Randomized trial of intravenous versus bidirectional chemotherapy after cytoreductive surgery for malignant peritoneal mesothelioma
por: Sugarbaker, Paul H.
Publicado: (2023)